Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:16 PM
Ignite Modification Date:
2025-12-24 @ 11:16 PM
NCT ID:
NCT00369356
Eligibility Criteria:
Inclusion Criteria:
* Patients with diagnosed CAD (either SVD or MVD) with signs or symptoms of myocardial ischemia, scheduled for percutaneous revascularization are all candidates.
* Either native vessels and SVG can be included with de-novo or recurrent lesions.
* Lesions causing a diameter stenosis \>50% in a main coronary artery (LAD, RCA, LCx) or their principal branches (Dg, OM, PL, PDA).
Exclusion Criteria:
* Diabetes
* Age over 80 years old
* Recent Q wave myocardial infarction (less than 2 weeks)
* Severe hypertension, uncontrolled despite medical treatment
* Gastric ulcer or symptomatic gastritis
* Neoplasia
* Renal failure (creatinine \>2.5)
* Left main disease, or left main equivalent (proximal LAD and proximal LCx), or three vessel disease involving the proximal segments of the 3 main coronary branches
* Suboptimal angiographic result of PCI (DS% \>30% or TIMI flow \<grade 3)
* Contraindications to high-doses of steroids (immunosuppression, active infective disease, osteoporosis, recent use of high doses of steroids).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT00369356
Study Brief:
Protocol Section:
NCT00369356